TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34311533

Group type: EXPERIMENTAL
Intervention: Mastiha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35859928

Group type: EXPERIMENTAL
Intervention: High serum IL6_0 (≥3.67 pg/mL)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: High serum TNFα_0 (≥14.8 pg/mL)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: High IL6_0 and high IL6_5 levels
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: High IL6_0
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: High IL6_5 level
Number of subjects: 135
Study: 34182948

Group type: EXPERIMENTAL
Intervention: Vaginal birth stories
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Caesarean birth stories
Number of subjects: 426
Study: 36071401

Group type: EXPERIMENTAL
Intervention: Co-created interventions in addition to standard of care
Number of subjects: 700

Group type: COMPARATOR
Intervention: Standard of care (routine clinical assessment every 3 months)
Number of subjects: 700
Study: 32722250

Group type: EXPERIMENTAL
Intervention: 500 mg Probiotic (Saccharomyces cerevisiae CNCM I-3856)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1000 mg Probiotic (Saccharomyces cerevisiae CNCM I-3856)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic (Saccharomyces cerevisiae CNCM I-3856)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 36384550

Group type: EXPERIMENTAL
Intervention: HLI-based self-care education program (4 sessions of 1.5 hours each)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 32203735

Group type: EXPERIMENTAL
Intervention: Local priming
Number of subjects: 0

Group type: COMPARATOR
Intervention: Global priming
Number of subjects: 0
Study: 34313232

Group type: EXPERIMENTAL
Intervention: Third-generation dual-source CT scanner (group A)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Second-generation dual-source CT scanner (group B)
Number of subjects: 131
Study: 32444035

Group type: EXPERIMENTAL
Intervention: Barberry extract (500 mg, 6 capsules daily for 3 months)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 35578351

Group type: EXPERIMENTAL
Intervention: Intervention group (complex intervention to encourage deprescribing antidepressants)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group (enhanced care as usual)
Number of subjects: 330
Study: 34541630

Group type: EXPERIMENTAL
Intervention: Hormonal oral contraceptive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Image-guided aspiration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound with color Doppler
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CA 125 plasma level or ROMA algorithm
Number of subjects: 0
Study: 32541618

Group type: EXPERIMENTAL
Intervention: Bilateral training (n = 12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Unilateral training (n = 11)
Number of subjects: 23
Study: 34170781

Group type: EXPERIMENTAL
Intervention: COVID-19 positive patients
Number of subjects: 200

Group type: COMPARATOR
Intervention: COVID-19 negative patients
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Patients with COVID-19 and VAEs
Number of subjects: 200

Group type: COMPARATOR
Intervention: Patients without COVID-19 and VAEs
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Progressive ARDS in patients with COVID-19
Number of subjects: 200

Group type: COMPARATOR
Intervention: Progressive ARDS in patients without COVID-19
Number of subjects: 200
Study: 33217088

Group type: EXPERIMENTAL
Intervention: Current major depressive disorder
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Past depressive episode
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Recurrent depressive disorder
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Current depressive disorder
Number of subjects: 177
Study: 35435541

Group type: EXPERIMENTAL
Intervention: Quantity + Quality blended PL group (SSPlay)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Quality group with play-based recess only (Play)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: SSPlay and Play groups combined
Number of subjects: 79
Study: 32586427

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTi)
Number of subjects: 99
Study: 35999166

Group type: EXPERIMENTAL
Intervention: Intervention group (124 patients)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (126 patients)
Number of subjects: 250
Study: 33478260

Group type: EXPERIMENTAL
Intervention: Blue-green light of 12,000 lux (experimental)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dim red light of 5 lux (control)
Number of subjects: 0
Study: 32661756

Group type: EXPERIMENTAL
Intervention: Dienogest (DNG) for 4 months preoperatively (group D)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone (GnRH) agonist for 4 months preoperatively (group G)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dienogest (DNG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone (GnRH) agonist
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dienogest (DNG) and Gonadotropin-releasing hormone (GnRH) agonist
Number of subjects: 70
Study: 35644672

Group type: EXPERIMENTAL
Intervention: Double dosage of 23-valent pneumococcal polysaccharide vaccine (PPV23) in WLPs
Number of subjects: 139

Group type: COMPARATOR
Intervention: Normal dosage of 23-valent pneumococcal polysaccharide vaccine (PPV23) in WLPs
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Double dosage of pneumococcal vaccines in KTRs
Number of subjects: 139

Group type: COMPARATOR
Intervention: Normal dosage of pneumococcal vaccines in KTRs
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Double dosage of pneumococcal vaccines in WLPs
Number of subjects: 139
Study: 33622389

Group type: EXPERIMENTAL
Intervention: Oxytocin (48 IU/day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 32825665

Group type: EXPERIMENTAL
Intervention: Direct outreach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional referral
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best practice advisory (BPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All methods combined
Number of subjects: 0
Study: 34184576

Group type: EXPERIMENTAL
Intervention: Early lactate-guided treatment
Number of subjects: 82

Group type: COMPARATOR
Intervention: Regular treatment (control group)
Number of subjects: 82
Study: 34516655

Group type: EXPERIMENTAL
Intervention: Selenium (200 μg) and Vitamin E (400 units) for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35656824

Group type: EXPERIMENTAL
Intervention: Ticagrelor‐aspirin
Number of subjects: 6412

Group type: COMPARATOR
Intervention: Clopidogrel‐aspirin
Number of subjects: 6412
Study: 33245938

Group type: EXPERIMENTAL
Intervention: Bilateral transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Anticholinergics
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham TTNS
Number of subjects: 17
Study: 33439557

Group type: EXPERIMENTAL
Intervention: e.max Press
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Initial LiSi Press
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 105
Study: 35869572

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy for 12 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33484896

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) thrice-weekly for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) daily doses of 12.5 mg for 12 weeks
Number of subjects: 60
Study: 35241434

Group type: EXPERIMENTAL
Intervention: L-PF Dyspnoea score
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: L-PF Cough score
Number of subjects: 542
Study: 32151287

Group type: EXPERIMENTAL
Intervention: Wild blueberry (WBB) supplementation (253 mg anthocyanins daily for 4 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Matched placebo supplementation
Number of subjects: 64
Study: 35988194

Group type: EXPERIMENTAL
Intervention: Nanomaterial-loaded clarithromycin (CLA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Clarithromycin capsules (Control)
Number of subjects: 120
Study: 33080765

Group type: EXPERIMENTAL
Intervention: Thrower's Ten exercises
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 34226933

Group type: EXPERIMENTAL
Intervention: Shaving waivers
Number of subjects: 10383

Group type: COMPARATOR
Intervention: No shaving waivers (control group)
Number of subjects: 10383
Study: 32918135

Group type: EXPERIMENTAL
Intervention: 400 μg FA/day
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: 3 g creatine
Number of subjects: 622

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 622
Study: 32434399

Group type: EXPERIMENTAL
Intervention: Combined multimarker screening for pre-eclampsia (maternal medical history, mean arterial pressure, placental growth factor, pregnancy associated plasma protein-A, Uterine artery mean pulsatility index)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin at a dose of 150 mg at bedtime
Number of subjects: 0
Study: 34493525

Group type: EXPERIMENTAL
Intervention: Single session of education and exercise
Number of subjects: 152

Group type: COMPARATOR
Intervention: Multiple sessions (6 sessions over 12 weeks) of education and exercise
Number of subjects: 152
Study: 32423621

Group type: EXPERIMENTAL
Intervention: SBRT with immediate ADT (continuous ADT, n = 7; intermittent ADT, n = 32)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: SBRT with immediate ADT
Number of subjects: 88

Group type: COMPARATOR
Intervention: SBRT with delayed ADT
Number of subjects: 88
Study: 33252489

Group type: EXPERIMENTAL
Intervention: Intervention (psychosocial counseling, systems navigation, and antiretroviral treatment)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 502
Study: 32993604

Group type: EXPERIMENTAL
Intervention: PHQ-9
Number of subjects: 109
Study: 616277788

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 985

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 985
Study: 35725486

Group type: EXPERIMENTAL
Intervention: Novel design house with elevated bedrooms and permeable screened walls
Number of subjects: 1650

Group type: COMPARATOR
Intervention: Traditional houses
Number of subjects: 1650
Study: 34627684

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 469

Group type: COMPARATOR
Intervention: Conventional infertility treatment
Number of subjects: 469
Study: 33526728

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet treatment with aspirin 100‐160 mg once daily and clopidogrel 75 mg once daily for three months (Group A)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Aspirin 100‐160 mg once daily for three months (Group B)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (Group C) treated according to appropriate treatment guidelines
Number of subjects: 165
Study: 34814819

Group type: EXPERIMENTAL
Intervention: Darbepoetin Alfa (DPA)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Epoetin Alfa (EPA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both treatments (DPA and EPA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: C-Reactive Protein (CRP) measurement
Number of subjects: 98
Study: 34464231

Group type: EXPERIMENTAL
Intervention: Optimal response adaptive design for treatment allocation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed randomization (1:1 or 2:1)
Number of subjects: 0
Study: 32014125

Group type: EXPERIMENTAL
Intervention: ropeginterferon alfa-2b
Number of subjects: 306

Group type: COMPARATOR
Intervention: hydroxyurea
Number of subjects: 306
Study: 34474433

Group type: EXPERIMENTAL
Intervention: CV̇O2 (42.49 ± 3.22 ml·kg−1·min−1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CV̇O2slow (38.26 ± 2.43 ml·kg−1·min−1)
Number of subjects: 9
Study: 36026699

Group type: EXPERIMENTAL
Intervention: Desensitizing mouth rinses (Colgate Sensitive, Elmex Sensitive Professional, Listerine Advanced Defense Sensitive, Sensodyne Cool Mint)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Conventional mouth rinses (Colgate Plax, Elmex Caries Protection, Listerine Anticaries, Sensodyne Pronamel)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Positive control (Clinpro XT Varnish)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative control (distilled water)
Number of subjects: 40
Study: 33896804

Group type: EXPERIMENTAL
Intervention: Thoracic Manipulation Group (TMG:50)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control Group (CG:30)
Number of subjects: 80
Study: 32967775

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 4 g daily (2 g BID with food)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (paraffin oil 2 g BID with food)
Number of subjects: 13
Study: 35412878

Group type: EXPERIMENTAL
Intervention: Three Good Things exercise
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study: 33064247

Group type: EXPERIMENTAL
Intervention: Teaching emotive English bed-night tales
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 25
Study: 32219386

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 616744462

Group type: EXPERIMENTAL
Intervention: High-intensity training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate-intensity training
Number of subjects: 0
Study: 34756158

Group type: EXPERIMENTAL
Intervention: Propensity score-integrated power prior approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm from RCT
Number of subjects: 0
Study: 34508656

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35849020

Group type: EXPERIMENTAL
Intervention: FAMily‐Oriented Support (FAMOS) family therapy program, includes seven home-based psychotherapeutic sessions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 62
Study: 34218195

Group type: EXPERIMENTAL
Intervention: Driver feedback
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Driver feedback plus financial incentives
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 174
Study: 34620799

Group type: EXPERIMENTAL
Intervention: Aflibercept treatment (intravitreal injections)
Number of subjects: 19
Study: 33465658

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention plus usual care
Number of subjects: 483

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 483
Study: 32557868

Group type: EXPERIMENTAL
Intervention: Adapted resistance training with instability
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional motor rehabilitation
Number of subjects: 32
Study: 35979046

Group type: EXPERIMENTAL
Intervention: Nurse-led pain management based on the Precede-Proceed model
Number of subjects: 410

Group type: COMPARATOR
Intervention: Conventional routine pain care (control group)
Number of subjects: 410
Study: 33514300

Group type: EXPERIMENTAL
Intervention: Qualitative examination of dyadic experience loss
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Open-ended questions about the dyadic relationship
Number of subjects: 29
Study: 33356580

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW); six 30-min ankle baths throughout the first 24 hours post-injury, administered every 4 hours.
Number of subjects: 18

Group type: COMPARATOR
Intervention: RICE protocol; rest, ice packs for 20 min every 3 hours, compression with elastic bandage for 24 hours, elevation above heart level.
Number of subjects: 18
Study: 34057922

Group type: EXPERIMENTAL
Intervention: Pakistani almonds (10g/day for 12 weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: American almonds (10g/day for 12 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 150
Study: 33887475

Group type: EXPERIMENTAL
Intervention: Budesonide oral suspension (BOS) 2.0 mg twice daily
Number of subjects: 318
Study: 34218667

Group type: EXPERIMENTAL
Intervention: Stochastic, spatially resolved, transmission model (Global Epidemic and Mobility model)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Different ranking strategies for site selection
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Proportional allocation of participants to sites based on projected incidence
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Geographically dispersed site combinations
Number of subjects: 100
Study: 32783280

Group type: EXPERIMENTAL
Intervention: Hybrid method (using loose seeds in combination with stranded seeds)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Conventional method (using loose seed alone)
Number of subjects: 219
Study: 34470913

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation (0.3 g/kg body mass) with warm-up
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study: 32871397

Group type: EXPERIMENTAL
Intervention: 8-week neuromuscular training program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Typical training routine (Control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison of experimental and control groups at post-testing
Number of subjects: 24
Study: 35971801

Group type: EXPERIMENTAL
Intervention: miRNA-based prognostic model using miR-3147, miR-4513, and miR-4728-5p along with pathological T stage and Gleason score
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Low prediction index
Number of subjects: 295
Study: 34424743

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 125

Group type: COMPARATOR
Intervention: Tungsten carbide bur
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Finishing with laser beams (Er,Cr:YSGG, Waterlase) with polishing with Sof‐Lex discs
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Finishing with a bur (tungsten carbide, Reliance) with polishing with Sof‐Lex discs
Number of subjects: 125
Study: 32883245

Group type: EXPERIMENTAL
Intervention: Intradialytic cognitive training (CT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training (ET)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combined cognitive training + exercise training (CT + ET)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care (SC)
Number of subjects: 200
Study: 35688618

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Non-modifiable factors
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Modifiable factors
Number of subjects: 591
Study: 34165447

Group type: EXPERIMENTAL
Intervention: Hydrotherapy (pool group)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Gym kinesitherapy (gym group)
Number of subjects: 115
Study: 32866454

Group type: EXPERIMENTAL
Intervention: Patient-activation tools (3-minute video and 1-page checklist) delivered prior to cardiology clinic visits
Number of subjects: 305

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 305
Study: 35418868

Group type: EXPERIMENTAL
Intervention: Drugs for GERD
Number of subjects: 380218
Study: 33214093

Group type: EXPERIMENTAL
Intervention: IVIg (400 mg/kg, IV, daily for three days)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (hydroxychloroquine, lopinavir/ritonavir, and supportive care)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: IVIg initiation timing
Number of subjects: 84
Study: 32660770

Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Plecanatide 6 mg
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study: 35988343

Group type: EXPERIMENTAL
Intervention: Judo training program (120 min per week for three months)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 57
Study: 34527921

Group type: EXPERIMENTAL
Intervention: Orofacial exercise program twice a day for one month in addition to oral hygiene care advices (Group 1)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Oral hygiene care advices for the first month followed by orofacial exercise program for the next month (Group 2)
Number of subjects: 56
Study: 32693858

Group type: EXPERIMENTAL
Intervention: Nutritional education curriculum
Number of subjects: 2660

Group type: COMPARATOR
Intervention: Control group (no nutritional education)
Number of subjects: 2660
Study: 34818976

Group type: EXPERIMENTAL
Intervention: Ischaemic compression (IC) + standard rehabilitation program (n=23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Instrument-assisted soft tissue mobilization (IASTM) + standard rehabilitation program (n=23)
Number of subjects: 46
Study: 36027955

Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous amoxicillin and clavulanic acid
Number of subjects: 3225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanic acid administration
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Episiotomy
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Forceps
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Primiparity
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Body mass index 25-29.9 kg/m2
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Body mass index ≥30 kg/m2
Number of subjects: 3225

Group type: EXPERIMENTAL
Intervention: Timing of antibiotic administration
Number of subjects: 3225
Study: 33663478

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (six two-hour courses)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (86 students)
Number of subjects: 143
Study: 36047047

Group type: EXPERIMENTAL
Intervention: Test preparation of hydroxychloroquine (200 mg tablet)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Reference preparation of hydroxychloroquine (200 mg tablet)
Number of subjects: 180
Study: 33549496

Group type: EXPERIMENTAL
Intervention: Research training and ongoing support for CPs
Number of subjects: 10